| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Hsien-Yuan Lane, Yue-Cune Chang, Chi-Chiang Chiu, Tzu-Ting Chen, Sue-Hong Lee, Wen-Ho Chan. Influences of patient-related variables on risperidone efficacy for acutely exacerbated schizophrenia: analyses with rigorous statistics. Journal of clinical psychopharmacology. vol 22. issue 4. 2002-09-18. PMID:12172333. |
response predictors of risperidone or other newer atypical antipsychotics for schizophrenia treatment remain unclear. |
2002-09-18 |
2023-08-12 |
Not clear |
| Hsien-Yuan Lane, Yue-Cune Chang, Chi-Chiang Chiu, Tzu-Ting Chen, Sue-Hong Lee, Wen-Ho Chan. Influences of patient-related variables on risperidone efficacy for acutely exacerbated schizophrenia: analyses with rigorous statistics. Journal of clinical psychopharmacology. vol 22. issue 4. 2002-09-18. PMID:12172333. |
this study aimed to investigate the influence of patient demographics on risperidone efficacy for schizophrenia. |
2002-09-18 |
2023-08-12 |
Not clear |
| Hsien-Yuan Lane, Yue-Cune Chang, Chi-Chiang Chiu, Tzu-Ting Chen, Sue-Hong Lee, Wen-Ho Chan. Influences of patient-related variables on risperidone efficacy for acutely exacerbated schizophrenia: analyses with rigorous statistics. Journal of clinical psychopharmacology. vol 22. issue 4. 2002-09-18. PMID:12172333. |
one hundred twenty-one newly hospitalized patients who had schizophrenia with acute exacerbation entered this prospective, 6-week risperidone trial. |
2002-09-18 |
2023-08-12 |
Not clear |
| Edoardo Spina, Angela Avenoso, Maria Gabriella Scordo, Maria Ancione, Aldo Madia, Giuliana Gatti, Emilio Perucc. Inhibition of risperidone metabolism by fluoxetine in patients with schizophrenia: a clinically relevant pharmacokinetic drug interaction. Journal of clinical psychopharmacology. vol 22. issue 4. 2002-09-18. PMID:12172343. |
inhibition of risperidone metabolism by fluoxetine in patients with schizophrenia: a clinically relevant pharmacokinetic drug interaction. |
2002-09-18 |
2023-08-12 |
human |
| Edoardo Spina, Angela Avenoso, Maria Gabriella Scordo, Maria Ancione, Aldo Madia, Giuliana Gatti, Emilio Perucc. Inhibition of risperidone metabolism by fluoxetine in patients with schizophrenia: a clinically relevant pharmacokinetic drug interaction. Journal of clinical psychopharmacology. vol 22. issue 4. 2002-09-18. PMID:12172343. |
the effect of fluoxetine on the steady-state plasma concentrations of risperidone and its active metabolite 9-hydroxyrisperidone (9-oh-risperidone) was evaluated in 10 patients with schizophrenia or schizoaffective disorder. |
2002-09-18 |
2023-08-12 |
human |
| Carol E Koro, Donald O Fedder, Gilbert J L'Italien, Sheila S Weiss, Laurence S Magder, Julie Kreyenbuhl, Dennis A Revicki, Robert W Buchana. Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study. BMJ (Clinical research ed.). vol 325. issue 7358. 2002-09-04. PMID:12153919. |
assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study. |
2002-09-04 |
2023-08-12 |
Not clear |
| I D Glick, P H Ber. Time to study discontinuation, relapse, and compliance with atypical or conventional antipsychotics in schizophrenia and related disorders. International clinical psychopharmacology. vol 17. issue 2. 2002-08-26. PMID:11890188. |
to more clearly clarify the efficacy of the atypical antipsychotics compared to conventional antipsychotics, we add data on the outcome of patients diagnosed with schizophrenia from two large, international clinical trials comparing olanzapine with haloperidol (n = 1996) and olanzapine with risperidone (n = 339). |
2002-08-26 |
2023-08-12 |
Not clear |
| Andrew M McIntos. Risperidone reduced the risk of relapse in outpatient schizophrenia and schizoaffective disorder. Evidence-based mental health. vol 5. issue 3. 2002-08-15. PMID:12180444. |
risperidone reduced the risk of relapse in outpatient schizophrenia and schizoaffective disorder. |
2002-08-15 |
2023-08-12 |
Not clear |
| Gwenaëlle Le Pen, Jean-Luc Morea. Disruption of prepulse inhibition of startle reflex in a neurodevelopmental model of schizophrenia: reversal by clozapine, olanzapine and risperidone but not by haloperidol. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 27. issue 1. 2002-08-08. PMID:12062902. |
disruption of prepulse inhibition of startle reflex in a neurodevelopmental model of schizophrenia: reversal by clozapine, olanzapine and risperidone but not by haloperidol. |
2002-08-08 |
2023-08-12 |
rat |
| Igor Elman, David S Goldstein, Alan I Green, Graeme Eisenhofer, Carol J Folio, Courtney S Holmes, David Pickar, Alan Breie. Effects of risperidone on the peripheral noradrenegic system in patients with schizophrenia: a comparison with clozapine and placebo. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 27. issue 2. 2002-08-07. PMID:12093603. |
effects of risperidone on the peripheral noradrenegic system in patients with schizophrenia: a comparison with clozapine and placebo. |
2002-08-07 |
2023-08-12 |
Not clear |
| Hassan S Dinakar, Robert N Sobel, James H Bopp, Anita Daniels, Sondra Maur. Efficacy of olanzapine and risperidone for treatment-refractory schizophrenia among long-stay state hospital patients. Psychiatric services (Washington, D.C.). vol 53. issue 6. 2002-08-01. PMID:12045315. |
efficacy of olanzapine and risperidone for treatment-refractory schizophrenia among long-stay state hospital patients. |
2002-08-01 |
2023-08-12 |
Not clear |
| Hassan S Dinakar, Robert N Sobel, James H Bopp, Anita Daniels, Sondra Maur. Efficacy of olanzapine and risperidone for treatment-refractory schizophrenia among long-stay state hospital patients. Psychiatric services (Washington, D.C.). vol 53. issue 6. 2002-08-01. PMID:12045315. |
the authors studied the efficacy of olanzapine and risperidone among patients with treatment-refractory schizophrenia who had been hospitalized for more than five years and who were not suitable candidates for a clozapine trial. |
2002-08-01 |
2023-08-12 |
Not clear |
| A Eden Evins, Ed Amico, Thomas A Posever, Rob Toker, Donald C Gof. D-Cycloserine added to risperidone in patients with primary negative symptoms of schizophrenia. Schizophrenia research. vol 56. issue 1-2. 2002-07-31. PMID:12084415. |
d-cycloserine added to risperidone in patients with primary negative symptoms of schizophrenia. |
2002-07-31 |
2023-08-12 |
Not clear |
| A Eden Evins, Ed Amico, Thomas A Posever, Rob Toker, Donald C Gof. D-Cycloserine added to risperidone in patients with primary negative symptoms of schizophrenia. Schizophrenia research. vol 56. issue 1-2. 2002-07-31. PMID:12084415. |
the purpose of this study was to examine the effects of d-cycloserine when added to risperidone on negative symptoms of schizophrenia. |
2002-07-31 |
2023-08-12 |
Not clear |
| Tyrone D Cannon, Matti O Huttunen, Minna Dahlström, Ilkka Larmo, Pirkko Räsänen, Alo Jurilo. Antipsychotic drug treatment in the prodromal phase of schizophrenia. The American journal of psychiatry. vol 159. issue 7. 2002-07-25. PMID:12091205. |
the safety and tolerability of short-term treatment with a low dose of risperidone was evaluated in adolescents with prodromal symptoms and a family history of schizophrenia. |
2002-07-25 |
2023-08-12 |
Not clear |
| X Cao, W Wan. [Comparison between therapeutic effect of Risperidone in treating different traditional Chinese medicine syndrome types of first-episode schizophrenia]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine. vol 20. issue 6. 2002-07-23. PMID:11789223. |
[comparison between therapeutic effect of risperidone in treating different traditional chinese medicine syndrome types of first-episode schizophrenia]. |
2002-07-23 |
2023-08-12 |
Not clear |
| X Cao, W Wan. [Comparison between therapeutic effect of Risperidone in treating different traditional Chinese medicine syndrome types of first-episode schizophrenia]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine. vol 20. issue 6. 2002-07-23. PMID:11789223. |
to study the therapeutic effect, side effects and cognize improvement of risperidone in treating different tcm syndrome-types of first-episode schizophrenia. |
2002-07-23 |
2023-08-12 |
Not clear |
| Jovan Simeon, Robert Milin, Selena Walke. A retrospective chart review of risperidone use in treatment-resistant children and adolescents with psychiatric disorders. Progress in neuro-psychopharmacology & biological psychiatry. vol 26. issue 2. 2002-07-22. PMID:11817503. |
charts for 106 children and adolescents (males n = 81 or 76.4%; females n = 25 or 23.6%), presenting with attention deficit and/or hyperactivity disorder (n = 49 or 46.2%), conduct disorder (n = 13 or 12.3%), oppositional-defiant disorder (n = 5 or 4.7%), behavioural problems not otherwise specified (n = 2 or 1.9%), autism (n = 8 or 7.5%), asperger's syndrome (n = 8 or 7.5%), pervasive developmental disorder (pdd) not otherwise specified (n = 4 or 3.8%), anxiety (n = 6 or 5.7%), depression (n = 2 or 1.9%), dysthymia (n = 2 or 1.9%), schizophrenia (n = 4 or 3.8%), adjustment disorder (n = 1 or 0.9%) and obsessive-compulsive disorder (n = 2 or 1.9%) were reviewed retrospectively to determine the tolerability and potential efficacy of risperidone treatment for a variety of psychiatric disorders. |
2002-07-22 |
2023-08-12 |
human |
| Glen L Stimmel, Mary A Gutierrez, Vivian Le. Ziprasidone: an atypical antipsychotic drug for the treatment of schizophrenia. Clinical therapeutics. vol 24. issue 1. 2002-07-10. PMID:11833834. |
over the past decade, use of the atypical antipsychotic drugs clozapine, risperidone, olanzapine, and quetiapine has significantly changed the treatment of schizophrenia in the united states. |
2002-07-10 |
2023-08-12 |
Not clear |
| Ahmed Aboraya, Jennifer Schumacher, Ehab Abdalla, James LePage, Melanie McGhee, Deborah Butcher, Holly Griffin, Mohammed Shahd. Neuroleptic malignant syndrome associated with risperidone and olanzapine in first-episode schizophrenia. The West Virginia medical journal. vol 98. issue 2. 2002-07-03. PMID:12048741. |
neuroleptic malignant syndrome associated with risperidone and olanzapine in first-episode schizophrenia. |
2002-07-03 |
2023-08-12 |
Not clear |